The first COVID-19 inoculations could be administered Tuesday in Connecticut to frontline medical personnel.
Pfizer
Posted inHealth
First doses of COVID vaccine could be administered in CT in mid-December
The state is expected to get its first shipment of COVID vaccines as early as Dec. 14.
Posted inHealth
‘It has to do with trust:’ Outreach on COVID vaccine begins in communities of color
Longstanding health disparities have amplified during the pandemic, creating ‘heightened levels of mistrust.’
Posted inNews
State’s vaccine panel weighs who should be first in line for COVID vaccine
The panel is analyzing who should receive the first doses of a coronavirus vaccine and devising strategies for public outreach.
Posted inPolitics
Connecticut sends COVID-19 distribution plan to CDC
The proposal calls for a three-stage distribution plan, but complex logistics remain unresolved.
Posted inHealth
Lamont announces membership of COVID vaccine advisory group
The new group, representing broad swath of interests, will help determine who first gets the vaccine.
Posted inHealth
Doubts about COVID-19 vaccine have spurred calls for transparency from Pfizer, other pharmaceuticals
‘The trust is not there,’ said Yale cardiologist Harlan Krumholz.
Posted inHealth
COVID-19 vaccine makers seek diversity in clinical trials in Connecticut and elsewhere
While Blacks and Latinos are hardest hit by the coronavirus, they are wary of participating in vaccine trials.
Posted inHealth
Pfizer’s Groton site helped develop a COVID-19 vaccine. Now the question is, will it work?
Pfizer CEO Albert Bourla said he expects to know, by the end of October, ‘whether the product works or not.’
Posted inHealth
Pfizer, with a Connecticut presence, gets $1.95 billion to develop COVID-19 vaccine
“It’s remarkable what they’ve been able to do,” Gov. Ned Lamont said from Pfizer’s research and development site in Groton.
Posted inHealth
Drug prices keep rising despite efforts to address problem
Some days, the inflammation and pain from rheumatoid arthritis makes it almost impossible for Tracy Braun to even sit up. “Sometimes I can’t even get up on my own,” she said. Braun is among a growing number of Americans who are finding it difficult to afford needed medicines, and a solution to their problem in Washington D.C. may continue to be elusive.
Posted inHealth, Politics
Trump attempt to rein in drug prices may have limited success
WASHINGTON – The president’s spokesman says Trump still favors a plan to negotiate Medicare prices, but he did not mention it after a recent meeting with pharmaceutical executives, and his plans to speed FDA approval of new drugs may be hampered by his restrictions on new regulations and cuts to the federal workforce.
Posted inPolitics
Blumenthal wants foreign worker visas boosted — and program reformed
WASHINGTON — Sen. Richard Blumenthal wants to expand a program that allows U.S. companies to hire workers with specialized skills, but after allegations of abuses the senator also wants the program investigated.
Posted inMoney, Politics
DeLauro breaks with Obama, big CT firms on Pacific trade deal
WASHINGTON – Rep. Rosa DeLauro is on a collision course with President Obama and some of Connecticut’s largest companies over a proposed trade deal with 12 countries on the Pacific Rim that span from Chile to Japan. DeLauro, D-3rd District, has become a leading opponent of the president’s plans for the Trans-Pacific Partnership, or TPP.
Posted inNews
Op-Ed: Pfizer Inc. is active, vital, taxpaying part of Eastern Connecticut
Pfizer Inc. remains an important, vibrant, active, taxpaying part of the Groton, southeastern Connecticut, and Connecticut landscape.